Compounds > 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil
Page last updated: 2024-10-27

6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil and HIV Infections

6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil has been researched along with HIV Infections in 1 studies

6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil: an anti-HIV agent; structure in first source
6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil : A pyrimidone that is uracil which is substituted at positions 1, 5, and 6 by ethoxymethyl, isopropyl, and 3,5-dimethylbenzyl groups, respectively.

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, H1
Takashima, H1
Ubasawa, M1
Sekiya, K1
Inouye, N1
Baba, M1
Shigeta, S1
Walker, RT1
De Clercq, E1
Miyasaka, T1

Other Studies

1 other study available for 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil and HIV Infections

ArticleYear
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
    Journal of medicinal chemistry, 1995, Jul-21, Volume: 38, Issue:15

    Topics: Animals; Antiviral Agents; Benzyl Compounds; HIV Infections; HIV-1; Humans; Lymphocytes; Mice; Micro

1995